亳州市84例新型冠状病毒肺炎的辨证论治分析

Syndrome Differentiation-based Treatment of Novel Coronavirus Pneumonia in Bozhou,China:An Analysis of 84 Cases

目的分析安徽省亳州市84例新型冠状病毒肺炎患者的中医证候及辨证论治特点。方法观察新型冠状病毒肺炎患者的临床症状、舌象,进行辨证分型和辨证治疗。结果84例患者中,临床治疗期湿毒郁肺证54例,寒湿阻肺证26例,疫毒闭肺证4例,分别选用清肺排毒汤1、2、3号方治疗;恢复期肺脾气虚证68例,气阴两虚证16例,分别选用自拟康复1、2号方治疗。结论亳州市确诊的新型冠状病毒肺炎患者临床治疗期主要中医证型为湿毒郁肺证(湿热并重)、寒湿阻肺证(寒微湿重),疫毒闭肺证少见,恢复期肺脾气虚证多见,气阴两虚证少见。应根据国家卫生健康委员会制定的《新型冠状病毒肺炎诊疗方案(试行第六版)》和亳州市患者的证候特点进行辨证论治。

Objective To investigate the traditional Chinese medicine(TCM)syndromes of 84 patients with novel coronavirus pneumonia in Bozhou,China,as well as the characteristics of their syndrome differentiation-based treatment.Methods Clinical symptoms and tongue manifestation were observed for the patients with novel coronavirus pneumonia,and syndrome differentiation-based typing and treatment were performed.Results Among the 84 patients,54 had dampness-toxicity lung-stagnation syndrome,26 had the syndrome of cold-dampness obstructing the lung,and 4 had the syndrome of epidemic toxin obstructing the lung in the stage of clinical treatment,and they were treated with Qingfei Paidu Decoction 1,2,and 3,respectively;in the recovery stage,68 had the syndrome of Qi deficiency of lung and spleen and 16 had deficiency of both Qi and Yin,and they were treated with self-made Kangfu prescriptions 1 and 2,respectively.Conclusion For patients with a confirmed diagnosis of novel coronavirus pneumonia,dampness-toxicity lung-stagnation syndrome(with damp-heat)and syndrome of cold-dampness obstructing the lung(with slight coldness and severe damp)are the main TCM syndromes in the stage of clinical treatment,and the syndrome of epidemic toxin obstructing the lung is less common;in the recovery stage,syndrome of lung-spleen Qi deficiency is commonly seen,while deficiency of both Qi and Yin is less common.Syndrome differentiation-based treatment should be given based on the Diagnosis and Treatment Protocol for COVID-19(Trial Version 6)formulated by National Health Commission and the features of TCM syndromes in patients with novel coronavirus pneumonia in Bozhou.